Cite
ESR1 Methylation Measured in Cell-Free DNA to Evaluate Endocrine Resistance in Metastatic Breast Cancer Patients
MLA
Manouk K. Bos, et al. “ESR1 Methylation Measured in Cell-Free DNA to Evaluate Endocrine Resistance in Metastatic Breast Cancer Patients.” International Journal of Molecular Sciences, vol. 23, no. 10, May 2022, p. 5631. EBSCOhost, https://doi.org/10.3390/ijms23105631.
APA
Manouk K. Bos, Teoman Deger, Stefan Sleijfer, John W. M. Martens, & Saskia M. Wilting. (2022). ESR1 Methylation Measured in Cell-Free DNA to Evaluate Endocrine Resistance in Metastatic Breast Cancer Patients. International Journal of Molecular Sciences, 23(10), 5631. https://doi.org/10.3390/ijms23105631
Chicago
Manouk K. Bos, Teoman Deger, Stefan Sleijfer, John W. M. Martens, and Saskia M. Wilting. 2022. “ESR1 Methylation Measured in Cell-Free DNA to Evaluate Endocrine Resistance in Metastatic Breast Cancer Patients.” International Journal of Molecular Sciences 23 (10): 5631. doi:10.3390/ijms23105631.